Three independent discounted-cash-flow-style models value DexCom, Inc. every trading day. 0 of 3 currently price DXCM above its market price.
| Free Cash Flow model | $13.69 |
| Excess Profit model | $24.28 |
| Residual Earnings model | $19.75 |
| Dividend Discount model | — |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +17.2% |
| Net debt / EBITDA | 0.6× |
| Gross margin | +60.1% |
| Revenue CAGR | +17.0% |
| Cash conversion | 1.7× |
| Dividend yield | — |
| Buyback yield | +0.9% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open DXCM in StockKitty